BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pemberton L, Swindell R, Sykes A. Primary Radical Radiotherapy for Squamous Cell Carcinoma of the Middle Ear and External Auditory Canal — an Historical Series. Clinical Oncology 2006;18:390-4. [DOI: 10.1016/j.clon.2006.03.001] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Oya R, Takenaka Y, Takemura K, Ashida N, Shimizu K, Kitamura T, Yamamoto Y, Uno A. Surgery With or Without Postoperative Radiation Therapy for Early-stage External Auditory Canal Squamous Cell Carcinoma: A Meta-analysis. Otology & Neurotology 2017;38:1333-8. [DOI: 10.1097/mao.0000000000001533] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
2 Sugimoto H, Hatano M, Yoshida S, Sakumoto M, Kato H, Ito M, Yoshizaki T. Efficacy of concurrent superselective intra-arterial chemotherapy and radiotherapy for late-stage squamous cell carcinoma of the temporal bone. Clin Otolaryngol 2015;40:500-4. [DOI: 10.1111/coa.12431] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
3 Zanoletti E, Lovato A, Stritoni P, Martini A, Mazzoni A, Marioni G. A critical look at persistent problems in the diagnosis, staging and treatment of temporal bone carcinoma. Cancer Treatment Reviews 2015;41:821-6. [DOI: 10.1016/j.ctrv.2015.10.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
4 Kang H, Wu H, Lee JH, Park CI, Kim C, Oh SH, Heo D, Kim D, Lee S. Role of Radiotherapy for Squamous Cell Carcinoma of the External Auditory Canal and Middle Ear. J Korean Soc Ther Radiol Oncol 2009;27:173. [DOI: 10.3857/jkstro.2009.27.4.173] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
5 Xie B, Zhang T, Dai C. Survival outcomes of patients with temporal bone squamous cell carcinoma with different invasion patterns. Head Neck 2015;37:188-96. [PMID: 24347537 DOI: 10.1002/hed.23576] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
6 Takenaka Y, Cho H, Nakahara S, Yamamoto Y, Yasui T, Inohara H. Chemoradiation therapy for squamous cell carcinoma of the external auditory canal: A meta-analysis. Head Neck 2015;37:1073-80. [PMID: 24692266 DOI: 10.1002/hed.23698] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 5.8] [Reference Citation Analysis]
7 Lionello M, Stritoni P, Facciolo M, Staffieri A, Martini A, Mazzoni A, Zanoletti E, Marioni G. Temporal bone carcinoma. Current diagnostic, therapeutic, and prognostic concepts: Temporal Bone Carcinoma. J Surg Oncol 2014;110:383-92. [DOI: 10.1002/jso.23660] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
8 Choi J, Kim SH, Koh YW, Choi EC, Lee CG, Keum KC. Tumor Stage-Related Role of Radiotherapy in Patients with an External Auditory Canal and Middle Ear Carcinoma. Cancer Res Treat 2017;49:178-84. [PMID: 27384159 DOI: 10.4143/crt.2016.165] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
9 Sugimoto H, Ito M, Yoshida S, Hatano M, Yoshizaki T. Concurrent Superselective Intra-Arterial Chemotherapy and Radiotherapy for Late-Stage Squamous Cell Carcinoma of the Temporal Bone. Ann Otol Rhinol Laryngol 2011;120:372-6. [DOI: 10.1177/000348941112000604] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
10 Anderson S, Patel P, Panizza B. Squamous Cell Carcinoma Extending to the Temporal Bone. In: Riffat F, Palme CE, Veness M, editors. Non-melanoma Skin Cancer of the Head and Neck. New Delhi: Springer India; 2015. pp. 131-43. [DOI: 10.1007/978-81-322-2497-6_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
11 Ueda Y, Kurita T, Matsuda Y, Ito S, Nakashima T. Superselective, intra-arterial, rapid infusion chemotherapy for external auditory canal carcinoma. J Laryngol Otol 2009;123:75-80. [DOI: 10.1017/s0022215109005143] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
12 Madsen AR, Gundgaard MG, Hoff CM, Maare C, Holmboe P, Knap M, Thomsen LL, Buchwald C, Hansen HS, Bretlau P, Grau C. Cancer of the external auditory canal and middle ear in Denmark from 1992 to 2001. Head Neck 2008;30:1332-8. [PMID: 18704969 DOI: 10.1002/hed.20877] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 4.2] [Reference Citation Analysis]
13 George M, Borsotti F, Gereige R, Kolethekkat AA, Das A, Messerer M, Mahasampath G, Simon C. A systematic review of the primary squamous cell carcinoma of the external auditory canal: survival outcome based on T-staging and proposal of a new classification. J Laryngol Otol 2021;135:96-103. [PMID: 33568243 DOI: 10.1017/S0022215121000323] [Reference Citation Analysis]
14 Wang Z, Zheng M, Xia S. The contribution of CT and MRI in staging, treatment planning and prognosis prediction of malignant tumors of external auditory canal. Clin Imaging 2016;40:1262-8. [PMID: 27639864 DOI: 10.1016/j.clinimag.2016.08.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 Nagano T, Yoshimura RI, Kojima M, Nakagawa K, Toda K. Outcomes of radiotherapy in advanced external auditory canal cancer. J Radiat Res 2019;60:380-6. [PMID: 31116854 DOI: 10.1093/jrr/rrz010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Zhong S, Zuo W. Treatment Strategies for Malignancies of the External Auditory Canal. Curr Treat Options Oncol 2022. [PMID: 35167009 DOI: 10.1007/s11864-021-00931-3] [Reference Citation Analysis]
17 Ogawa K, Nakamura K, Hatano K, Uno T, Fuwa N, Itami J, Kojya S, Nakashima T, Shinhama A, Nakagawa T, Toita T, Sakai M, Kodaira T, Suzuki M, Ito H, Murayama S. Treatment and Prognosis of Squamous Cell Carcinoma of the External Auditory Canal and Middle Ear: A Multi-Institutional Retrospective Review of 87 Patients. International Journal of Radiation Oncology*Biology*Physics 2007;68:1326-34. [DOI: 10.1016/j.ijrobp.2007.01.052] [Cited by in Crossref: 73] [Cited by in F6Publishing: 52] [Article Influence: 4.9] [Reference Citation Analysis]
18 Hayashi K, Koto M, Demizu Y, Saitoh JI, Suefuji H, Okimoto T, Ohno T, Shioyama Y, Takagi R, Ikawa H, Nemoto K, Nakano T, Kamada T. A retrospective multicenter study of carbon-ion radiotherapy for external auditory canal and middle ear carcinomas. Cancer Med 2019;8:51-7. [PMID: 30548207 DOI: 10.1002/cam4.1830] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
19 Masterson L, Rouhani M, Donnelly NP, Tysome JR, Patel P, Jefferies SJ, Roques T, Scrase C, Mannion R, Macfarlane R, Hardy D, Durrani A, Price R, Marker A, Axon P, Moffat DA. Squamous cell carcinoma of the temporal bone: clinical outcomes from radical surgery and postoperative radiotherapy. Otol Neurotol 2014;35:501-8. [PMID: 24492135 DOI: 10.1097/MAO.0000000000000265] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
20 Kitani Y, Kubota A, Furukawa M, Sato K, Nakayama Y, Nonaka T, Mizoguchi N. Primary definitive radiotherapy with or without chemotherapy for squamous cell carcinoma of the temporal bone. Eur Arch Otorhinolaryngol 2016;273:1293-8. [PMID: 25822291 DOI: 10.1007/s00405-015-3616-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
21 Fujiwara M, Yamamoto S, Doi H, Takada Y, Odawara S, Niwa Y, Ishikura R, Kamikonya N, Terada T, Uwa N, Sagawa K, Hirota S. Arterial chemoradiotherapy for carcinomas of the external auditory canal and middle ear: Carcinomas of the Lateral Skull Base. The Laryngoscope 2015;125:685-9. [DOI: 10.1002/lary.24908] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
22 Murai T, Kamata SE, Sato K, Miura K, Inoue M, Yokota N, Ohta S, Iwabuchi M, Iwata H, Shibamoto Y. Hypofractionated Stereotactic Radiotherapy for Auditory Canal or Middle Ear Cancer. Cancer Control 2016;23:311-6. [PMID: 27556672 DOI: 10.1177/107327481602300315] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
23 Katano A, Takenaka R, Yamashita H, Ando M, Yoshida M, Saito Y, Asakage T, Abe O, Nakagawa K. A retrospective analysis of radiotherapy in the treatment of external auditory canal carcinoma. Mol Clin Oncol 2021;14:45. [PMID: 33575029 DOI: 10.3892/mco.2021.2207] [Reference Citation Analysis]
24 Matoba T, Hanai N, Suzuki H, Nishikawa D, Tachibana E, Okada T, Murakami S, Hasegawa Y. Treatment and Outcomes of Carcinoma of the External and Middle Ear: The Validity of En Bloc Resection for Advanced Tumor. Neurol Med Chir (Tokyo) 2018;58:32-8. [PMID: 29142161 DOI: 10.2176/nmc.oa.2017-0133] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
25 Koto M, Hasegawa A, Takagi R, Sasahara G, Ikawa H, Mizoe J, Jingu K, Tsujii H, Kamada T, Okamoto Y; Organizing Committee for the Working Group for Head and Neck Cancer. Carbon ion radiotherapy for locally advanced squamous cell carcinoma of the external auditory canal and middle ear: Carbon ion radiotherapy for SCC of the ear. Head Neck 2016;38:512-6. [DOI: 10.1002/hed.23905] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
26 Correia-Rodrigues P, Ramalho S, Montalvão P, Magalhães M. External auditory canal carcinoma: clinical characteristics and long-term treatment outcomes. Eur Arch Otorhinolaryngol 2020;277:2709-20. [PMID: 32367152 DOI: 10.1007/s00405-020-06019-2] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Bacciu A, Clemente IA, Piccirillo E, Ferrari S, Sanna M. Guidelines for Treating Temporal Bone Carcinoma Based on Long-Term Outcomes. Otology & Neurotology 2013;34:898-907. [DOI: 10.1097/mao.0b013e318281e0a9] [Cited by in Crossref: 60] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
28 Gurgel RK, Karnell LH, Hansen MR. Middle ear cancer: A population-based study: Middle Ear Cancer. The Laryngoscope 2009;119:1913-7. [DOI: 10.1002/lary.20202] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
29 Jia X, Liang Q, Chi F. Treatment and outcome of middle ear cancer. Eur Arch Otorhinolaryngol 2014;271:2675-80. [DOI: 10.1007/s00405-013-2728-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
30 Xia S, Yan S, Zhang M, Cheng Y, Noel J, Chong V, Shen W. Radiological Findings of Malignant Tumors of External Auditory Canal: A Cross-Sectional Study Between Squamous Cell Carcinoma and Adenocarcinoma. Medicine (Baltimore) 2015;94:e1452. [PMID: 26334907 DOI: 10.1097/MD.0000000000001452] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]